NUI Galway awarded €490,000 from Enterprise Ireland Commercialisation Fund
Tuesday, 24 May 2005
The novel projects are across strategic commercial areas such as biomedical sensors, implantable medical devices, controls for waste water treatment plants, software development, optics and biomaterials. The six researchers are Professors Chris Dainty and Gerry Lyons, Drs Desmond Chambers, Vincent O'Flaherty, Dimitrious Apatsidis, Yury Rochev.
Successful projects under this programme will bring the research to a stage where a robust prototype will be developed. The proposed projects cover a wide range of potential applications and the funding was won against strong competition involving all the third level colleges in Ireland.
Séamus Bree, Director West Region, Enterprise Ireland said that innovation was the key to the future of Irish industry. "It is vitally important that we build and maintain a momentum in the development of intellectual property through the Third Level colleges. The commercialisation of technology from our strengthening research base is a key priority so that more growth-oriented companies will emerge in cutting edge sectors. I look forward to research initiatives such as these funded under the commercialisation fund in NUI Galway, resulting in either new campus companies or licensed technology into SMEs."
Dr Iognáid Ó Muircheartaigh, President of NUI Galway said: "We are delighted to receive this substantial award aimed at developing applied research which is critically important to the future economic growth of Ireland as we move from a manufacturing base to product design and intellectual property creation. Because of its strong research base, NUI Galway is ideally placed to support the Government's enterprise strategy of developing a knowledge-based society."